Flu Vaccine Supply Is Focus Of House Govt. Reform Hearing Feb. 10
This article was originally published in The Pink Sheet Daily
Executive Summary
CDC is expected to discuss efforts to combat local-level supply-and-demand mismatches. Sanofi Pasteur’s role in distributing federal emergency reserve doses and Chiron’s uncertain status for the 2005-2006 flu season are among the likely discussion topics.
You may also be interested in...
Chiron’s Fluvirin Distribution Contracts Under Discussion
The company and its vaccine distributors will determine whether contracts for 2004 will be extended for the next flu season given uncertainty over whether Fluvirin will be available. Additional clarity on Fluvirin supply is expected in “early spring.”
House Appropriations Subcommittee Plans FDA Hearing July 26
Ag/FDA subcommittee had tabled FDA hearing pending confirmation of a permanent agency commissioner. House cleared FDA 2006 spending in early June.
Second Quarter Earnings Season Heats Up
Amgen, J&J, Sanofi-Aventis, Pfizer, Merck, Roche, Lilly and Schering-Plough are scheduled to report results in upcoming week. Bristol could expand upon plans to sell OTC unit to Novartis the following week.